Evidence map›Paper›PMID 38967023›Full record

ArticleNucleic acids research2024

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system.

Danping Zhang, Liyang Du, Haishan Gao, Cai Yuan, Zhonghui Lin

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danping ZhangCollege of Chemistry, Fuzhou University, Fuzhou 350108, China.
Liyang DuCollege of Chemistry, Fuzhou University, Fuzhou 350108, China.
Haishan GaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.
Cai YuanCollege of Biological Science and Engineering, Fuzhou University, Fuzhou, China.
Zhonghui LinCollege of Chemistry, Fuzhou University, Fuzhou 350108, China.ORCID 0000-0001-5797-7347

Funding

National Natural Science Foundation of China 31971222
6 · The paper itself

Abstract

In the type III CRISPR system, cyclic oligoadenylate (cOA) molecules act as second messengers, activating various promiscuous ancillary nucleases that indiscriminately degrade host and viral DNA/RNA. Conversely, ring nucleases, by specifically cleaving cOA molecules, function as off-switches to protect host cells from dormancy or death, and allow viruses to counteract immune responses. The fusion protein Csx1-Crn2, combining host ribonuclease with viral ring nuclease, represents a unique self-limiting ribonuclease family. Here, we describe the structures of Csx1-Crn2 from the organism of Marinitoga sp., in both its full-length and truncated forms, as well as in complex with cA4. We show that Csx1-Crn2 operates as a homo-tetramer, a configuration crucial for preserving the structural integrity of the HEPN domain and ensuring effective ssRNA cleavage. The binding of cA4 to the CARF domain triggers significant conformational changes across the CARF, HTH, and into the HEPN domains, leading the two R-X4-6-H motifs to form a composite catalytic site. Intriguingly, an acetate ion was found to bind at this composite site by mimicking the scissile phosphate. Further molecular docking analysis reveals that the HEPN domain can accommodate a single ssRNA molecule involving both R-X4-6-H motifs, underscoring the importance of HEPN domain dimerization for its activation.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsAdenine NucleotidesModels, MolecularOligoribonucleotidesProtein BindingProtein DomainsProtein MultimerizationRibonucleases2',5'-oligoadenylateAdenine NucleotidesBacterial ProteinsCRISPR-Associated ProteinsOligoribonucleotidesRibonucleases

Identifiers

PMID38967023
PMCPMC11317161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.